Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site vesicles
Clinical narrative: More than 45 days to get second dose; Fatigue; Mild fever; Mild weakness, limited activity; Itching; Blister appeared next day on my arm on the same spot where the vaccine was injected; Minor bleeding; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Minor bleeding), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 45 days to get second dose), VACCINATION SITE VESICLES (Blister appeared next day on my arm on the same spot where the vaccine was injected), ASTHENIA (Mild weakness, limited activity) and VACCINATION SITE PRURITUS (Itching) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure since 15-Aug-2011. Concomitant products included ESOMEPRAZOLE from 15-Aug-2020 to an unknown date for Acid reflux (esophageal), LOSARTAN POTASSIUM from 07-Feb-2021 to an unknown date and NEBIVOLOL from 07-Feb-2021 to an unknown date for Hypertension.    On 15-Apr-2021 at 11:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced ASTHENIA (Mild weakness, limited activity) and PYREXIA (Mild fever). On 27-Apr-2021, the patient experienced FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE HAEMORRHAGE (Minor bleeding), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 45 days to get second dose), VACCINATION SITE VESICLES (Blister appeared next day on my arm on the same spot where the vaccine was injected) and VACCINATION SITE PRURITUS (Itching). The patient was treated with FUSIDATE SODIUM (FUCIDIN [FUSIDATE SODIUM]) (topical) for Blister, at a dose of 1 UNK. At the time of the report, VACCINATION SITE HAEMORRHAGE (Minor bleeding), VACCINATION SITE VESICLES (Blister appeared next day on my arm on the same spot where the vaccine was injected) and VACCINATION SITE PRURITUS (Itching) was resolving and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 45 days to get second dose), ASTHENIA (Mild weakness, limited activity), FATIGUE (Fatigue) and PYREXIA (Mild fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       PCR Covid Test- Saliva was done but no results were mentioned   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow up received on 05 JUL 2021: Updated patient demographics, Past medical history, Concomitant and treatment medications and Events and Event outcome. On 19-Jul-2021: Follow up received on 19 JUL 2021 and contains no new information On 20-Jul-2021: Follow up  additional 2 report received and contains no new information On 20-Jul-2021: Follow up additional information  received and contains no new information On 23-Jul-2021: Follow up additional information 3 received containing No New Information On 30-Jul-2021: Follow-up received on 30-Jul-2021 included no new information.